CADL
Candel Therapeutics·NASDAQ
--
--(--)
--
--(--)
CADL fundamentals
Candel Therapeutics (CADL) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.09 (YoY +87.84%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.09
+87.84%
Report date
Aug 14, 2025
Earnings Call
8:00 AM on Aug 12, 2025
Meeting link.EPS
Actual | -1.46 | -0.69 | 0.05 | -0.03 | -0.14 | -0.3 | -0.18 | -0.3 | -0.33 | -0.29 | -0.38 | -0.28 | -0.74 | -0.33 | -0.4 | 0.13 | -0.09 |
Forecast | -0.2297 | -0.2614 | -0.3083 | -0.0889 | -0.3918 | -0.3535 | -0.3061 | -0.3502 | -0.2986 | -0.19 | -0.16 | -0.2276 | -0.3746 | -0.1637 | |||
Surprise | -535.61% | -163.96% | +116.22% | +66.25% | +64.27% | +15.13% | +41.20% | +14.33% | -10.52% | -52.63% | -137.50% | 0.00% | 0.00% | 0.00% | -75.75% | +134.70% | +45.02% |
Revenue
Actual | -- | 31.00K | 32.00K | -- | 31.00K | 31.00K | 0 | 0 | 0 | 0 | -- | -- | -- | 0 | 0 | 0 | 0 |
Forecast | 6.67K | 13.33K | 15.00K | 20.67K | 0 | 15.50K | 13.00K | 0 | 0 | 0 | 0 | -- | -- | -- | 0 | 0 | 0 |
Surprise | 0.00% | +132.51% | +113.33% | 0.00% | 0.00% | +100.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Candel Therapeutics's gross profit margin?What were the key takeaways from Candel Therapeutics's earnings call?What is the revenue and EPS growth rate for Candel Therapeutics year over year?What is the market's earnings forecast for Candel Therapeutics next quarter?What factors drove the changes in Candel Therapeutics's revenue and profit?What does Candel Therapeutics do and what are its main business segments?What is Candel Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Candel Therapeutics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
